Thomas O. Daniel (Celgene Corporation)

The event will start on: Mon, Feb 10, 2014 | 4:00 pm
Location: Lewis Thomas Lab, 003 | Washington Road

Chief Scientific Officer Seminar Series

Sponsored by Office of Corporate Relations and Department of Molecular Biology


Thomas O. DanielThomas O. Daniel, M.D.


Dr. Thomas O. Daniel, M.D., has been Executive Vice President, President - Research and Early Development of Celgene Corp., since February 15, 2012. He has been President, Research and Early Development since December 2006. Previously he served as the Chief Scientific Officer at Ambrx Inc., as Vice President, Research at Amgen Inc., and as Senior Vice President of Discovery Research at Immunex. Dr. Daniel currently serves as a member of the Biomedical Science Advisory Board of Vanderbilt University Medical Center. A nephrologist and former academic investigator, Dr. Daniel was previously the K.M. Hakim Professor of Medicine and Cell Biology at Vanderbilt University, and Director of the Vanderbilt Center for Vascular Biology. He formerly conducted research in the Howard Hughes Medical Institute at UC San Francisco, earned an M.D. from the University of Texas, Southwestern, and completed medical residency at Massachusetts General Hospital.


Seminar Topic

Found in Translation: Paths from Leading Science to Transformative Medicines



Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

For more information, please visit



Free and open to the university community and the public

Hosted by: Bonnie Bassler, Molecular Biology

Upcoming Events

Wed, Sep 14, 2016

Tue, Sep 20, 2016

Wed, Sep 28, 2016

Contact Us

Lewis Thomas Laboratory at Princeton University

119 Lewis Thomas Laboratory
Washington Road, Princeton, NJ  08544-1014

Need help? Contact us

Fax: (609) 258-3980